The Jhunjhunwala family’s wealth in listed firms, which surpassed ₹50,000 crore for the first time in the March quarter, declined by nearly 8% to ₹47,053 crore by the end of the June quarter. Stocks like Titan, Crisil, and Sun Pharma Advanced Research fell between 10% and 35% during this period.
Motilal Oswal Alternates raises Rs 2,000 cr through sixth real estate fund
Motilal Oswal Alternates (MO Alternates), the alternative investments arm of Motilal Oswal Group, has raised over Rs 2,000 crores through final close of its sixth